These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9628241)

  • 1. Prevalence of diabetes-specific autoantibodies in patients at risk for adult onset diabetes mellitus.
    Breidert M; Temelkova-Kurktschiev T; Hanefeld M; Leonhardt W; Schmoeckel A; Seissler J
    Exp Clin Endocrinol Diabetes; 1998; 106(2):113-6. PubMed ID: 9628241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
    Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
    Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
    Martinka E; Ocenásová A; Straková J; Mokán M
    Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
    Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
    Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E; Sabuncu T; Ozer EM; Hatemi H
    J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].
    Schilling I; Conrad K; Füssel M; Henker J
    Dtsch Med Wochenschr; 2003 Jan; 128(5):185-9. PubMed ID: 12557109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
    Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
    Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
    Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide and autoimmune markers in diabetes.
    Törn C
    Clin Lab; 2003; 49(1-2):1-10. PubMed ID: 12593469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.